Searched for
GSK PHARMACEUTICALS
Novartis India MD Amitabh Dube appointed as OPPI presidentAmitabh Dube has been appointed as the new president of OPPI for a two-year term. Dube currently serves as the Country President and Managi...- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Laurus Labs among 5 stocks hitting 52-week highs; surge up to 20% in a monthSix BSE 200 stocks hit fresh 52-week highs on Friday as the Sensex gained 331 points. Coforge, GSK Pharma, Glenmark Pharma, Laurus Labs, Or...
- Ajanta Pharma among 5 midcap stocks to hit 52-week highs & surge up to 18% in a monthFive BSE Midcap stocks—KEI Industries, GSK Pharmaceuticals, Lenskart Solutions, Radico Khaitan and Ajanta Pharma—hit fresh 52-week highs de...
- Trump’s vaccine overhaul could bring more shots, higher costs for US familiesPresident Donald Trump's vaccine plan faces significant financial and logistical hurdles. Drugmakers must develop new manufacturing process...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- AstraZeneca 'magic' faces rare test after trial failure, share slideAstraZeneca's nerve drug Wainua unexpectedly failed a late-stage heart disease trial. This setback has caused investor concern and impacted...
- Global Market: Cerebras bets big on Europe with AI infrastructure expansion amid soaring demandCerebras is significantly increasing its European AI computing capacity. The company plans to reach 200 megawatts by next year. This expans...
- $10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...
- GSK sends notices to Akums, Associate over 'Zinetac' brandThe Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...
- Optimising product portfolio, focusing on key brands: GSK Pharmaceuticals"The business has embarked on it new strategy this year, as we put in place an optimal commercial structure and worked at building capabili...
- $1 billion bet: GSK Pharma a short-term sell, long-term buy, say expertsThe stock is at rich valuations despite low sales and profit growth. The open offer by its parent firm is attractively priced, say experts.
- No major surprise on GSK Pharma offer: Dipen ShanGSK, which holds 50.7 per cent stake, wants to raise up to 75 per cent at a price of Rs 3,100 a share.
- GSK Pharma rallies 20% as parent initiates open offerThe parent of GlaxoSmithKline Pharmaceuticals Ltd plans to increase its stake from 50.7 per cent to up to 75 per cent at an offer price of ...
- GlaxoSmithKline Pharmaceuticals Q3 net up 4.44% at Rs 152.34 croreGlaxoSmithKline today reported 4.44 per cent rise in net profit at Rs 152.34 crore for the quarter ended September 30, 2012 on back of robu...
- GlaxoSmithKline Pharma Q3 net dips 7.57% to Rs 145.86 crGSK Pharmaceuticals today reported 7.57 per cent decline in net profit for the third quarter ended September 30, 2011 to Rs 145.86 crore.
- Glaxo to step up capacity for elephantiasis drug productionBritish drugmaker GlaxoSmithKline (GSK) will increase its capacity to make a drug for the treatment of elephantiasis at its manufacturing f...
- GSK to lower prices to woo India mktGlaxoSmithKline CEO Andrew Witty says the pharma major plans to invest Rs 430 crore to develop vaccines here.
- Pharma cos may face penalties for overpricingDrugmakers, such as Dr Reddy’s Laboratories, Wyeth, GlaxoSmithKline (GSK) Pharmaceuticals and Alkem Laboratories, may now have to face stat...
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...
Load More
